Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for excessive daytime sleepiness in narcolepsy
2010-019687-36Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pitolisant in narcolepsy (3 arms), sponsored by Bioprojet. Primary endpoint: Change in Epworth Sleepiness Scale (ESS). Started Jun 2010; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2010-019687-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019687-36.